Gemini Therapeutics is a precision medicine company focused on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.
Gemini Therapeutics
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://www.geminitherapeutics.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address200 Cambridge Park Drive, 2nd Floor, MA 02140CambridgeUnited States
200 Cambridge Park Drive, 2nd Floor, MA 02140
Cambridge
United States
Contact Number+6174014400
+6174014400
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/geminitherapeutics” connections=”true” suffix=””]